Remote BV Management via Metagenomic Vaginal Microbiome Testing and Telemedicine
Bacterial vaginosis (BV) affects 30% of women annually, but many face barriers to in-person care. Here we present real-world outcomes of remote BV diagnosis and management through self-collected vaginal microbiome (VMB) testing and telemedicine visits, focusing on symptom resolution, recurrence, and...
Saved in:
Main Authors: | Krystal Thomas-White, Genevieve Olmschenk, David Lyttle, Rob Markowitz, Pita Navarro, Kate McLean |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/13/7/1623 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Temporal dynamics of the vaginal microbiome and host immune markers before, during, and after metronidazole treatment for bacterial vaginosis
by: Amanda Williams, et al.
Published: (2025-07-01) -
Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
by: A. B. Khuraseva, et al.
Published: (2018-11-01) -
Hormonal status in women of reproductive age with nonspecific vaginitis
by: O.D. Ryazanova
Published: (2023-03-01) -
Differential PCR diagnosis of bacterial vaginosis, aerobic vaginitis and vulvovaginal candidiasis
by: T. I. Makhova, et al.
Published: (2022-06-01) -
Real-world clinical burden of patients presenting with vaginitis symptoms in the United StatesAJOG MFM at a Glance
by: Justin Chen, et al.
Published: (2025-05-01)